Notice of NIDDK Participation in PAR-24-077: "Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)"
Notice Number:
NOT-DK-24-013

Key Dates

Release Date:

February 16, 2024

Related Announcements

  • December 01, 2023- Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional). See NOFO PAR-24-077
     

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this notice is to inform potential applicants that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) will participate, effective immediately, in PAR-24-077, “Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)"

Currently, Reads:

National Institute on Minority Health and Health Disparities (NIMHD)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Behavioral and Social Sciences Research (OBSSR)

Sexual and Gender Minority Research Office (SGMRO)

Currently, Reads:

Assistance Listing Number(s): 93.307, 93.279, 93.242, 93.273, 93.398

Modified to Read (in Bold):

Part 1. Overview Information

National Institute on Minority Health and Health Disparities (NIMHD)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

National Cancer Institute (NCI)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Behavioral and Social Sciences Research (OBSSR)

Sexual and Gender Minority Research Office (SGMRO)

Modified to Read (in Bold):

Assistance Listing Number(s): 93.307, 93.279, 93.242, 93.273, 93.398, 93.847

Modified to Read (in Bold):

Part 2. Section I. Notice of Funding Opportunity Description

Specific Areas of Research Interest

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIDDK is interested in applications using an intersectionality perspective to address health and health care disparities in NIDDK-related diseases and conditions in sexual and gender minority populations who are from minoritized racial and ethnic populations and/or from lower SES, focused on innovative observational, etiological, and/or intervention-based research. NIDDK mission diseases and conditions include diabetes and other endocrine and metabolic diseases; gastrointestinal, liver, and pancreatic diseases, nutritional disorders, and obesity; and kidney, urologic, and/or hematologic diseases. 

NIDDK encourages research conducted using an equity lens, which considers—at each decision point—how processes, values, assumptions, and actions may affect inclusive excellence in our research and workforce and the overall well-being and health of diverse population groups. 

NIDDK encourages applications that demonstrate consideration of the Tips for Pursuing Competent Health Equity Research (see Appendix G of Pathways to Health for All). This includes applications with interdisciplinary research teams comprised of individuals with a breadth of lived experiences and biomedical scientific expertise deemed necessary to positively inform the study design, research conduct, and applicability of research findings for the populations of interest. Successful applicants will also leverage community-engaged research approaches that meaningfully include people who identify with SGM groups, minoritized racial/ethnic and socio-economic statuses, and/or who are living with NIDDK disease/conditions. 

To be assigned to the NIDDK, applications must be directly related to the mission of the NIDDK (https://www.niddk.nih.gov/about-niddk/meet-director/mission-vision). NIDDK has many research areas within its mission, but all research related to relevant diseases may not be appropriate for NIDDK. Applicants are strongly encouraged to contact NIDDK staff as soon as possible in the development of the application, so that NIDDK staff can help the applicant understand whether the proposed project is within the goals and mission of the Institute.

Modified to Read (in Bold):

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

NIDDK conducts and supports medical research in diabetes and other endocrine and metabolic diseases; gastrointestinal, liver, and pancreatic diseases, nutritional disorders, and obesity; and in kidney, urologic, and hematologic diseases. Visit NIDDK's Research Programs and Contacts page to identify a scientific/research contact.

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Bonnie Burgess-Beusse, Ph.D.
Division of Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4726
Email: bonnie.burgess-beusse@nih.gov